Alector, Inc.

ALEC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-32.5M
Depreciation & Amortization $680.0K
Depreciation
Amortization
Stock-Based Compensation $5.4M
Net Cash from Operating Activities $-17.8M
Investing Activities
Capital Expenditures $801.0K
Business Acquisitions
Net Cash from Investing Activities $-801.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $-15.0K
Net Change in Cash $-18.6M
Free Cash Flow $-18.6M
← Newer Page 2 of 2 Older →